Navigation Links
Bioheart Announces Plans to Advance LVAD + Muscle Stem Cells Clinical Trial
Date:12/8/2010

SUNRISE, Fla., Dec. 8, 2010 /PRNewswire-FirstCall/ -- Bioheart, Inc. (OTC Bulletin Board: BHRT) announced today that at the American Heart Association Annual Meeting, it finalized the formation of a working group. The group's focus is to advance a BRIDGE TO RECOVERY clinical trial, combining a left ventricle assist device (LVAD) and Bioheart's MyoCell adult muscle stem cell composition and Bioheart's MyoCath needle tipped catheter delivery system.   Initial participants in developing this proposed protocol design include:Dr. Frank Pagani, University of MichiganDr. Warren Sherman, Columbia UniversityDr. Ernst Schwarz, Ceders Sinai UCLADr. Nabil Dib, University of California San Diego and Mercy Gilbert Hospital PhoenixDr. Carl Pepine, University of Florida Shands HospitalDr. Doris Taylor, University of MinnesotaThe expected study design pending potential modification will include 3 treatment arms: Group 1 - Patients receive MyoCell SDF-1 single dose via MyoCath catheter delivery after LVAD placement.Group 2 - Patients receive MyoCell in multiple injection sessions over 6 months via MyoCath catheter delivery following LVAD placement.Group 3 - Patients receive LVAD only. The end points in the trial will include exercise capacity, functional improvements and success in weaning off the LVAD."At the AHA meeting, improvements in survival of heart failure patients were reported from trials with battery powered pacers and mechanical left ventricle assist heart pumps.  These devices help patients cope with their failing heart, but do little to repair damaged scar tissue in the heart, which is often the primary source of heart failure.  The MyoCell composition from Bioheart has demonstrated an ability to grow new contractile muscle in scar tissue and thus, may actually address the underlying problem.  Supporting the patient with an LVAD temporarily during the time period
'/>"/>

SOURCE Bioheart, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
2. Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study
3. Bioheart Reports Promising Results From Preclinical Study of Adipose-Derived Acute Cell Therapy
4. Bioheart Announces 35 Leading U.S. Heart Failure Centers Engaged in Phase II/III Marvel Trial of Myogenic Cells for Treating Advanced Heart Failure
5. Leading Experts Endorse Biohearts Muscle Stem Cell MyoCell Therapy
6. Biohearts MyoCell Recognized as one of the Breakthrough Developments of 2010
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013  A recently published clinical study conducted at ... , demonstrates that 3D mammography (breast tomosynthesis) significantly ... The study, "Implementation of Breast Tomosynthesis in ... by Stephen L. Rose , MD, ... American Journal of Roentgenology (AJR). The AJR is ...
(Date:5/23/2013)... JERUSALEM , May 23, 2013  Hadasit Bio-Holdings ... portfolio of biotech companies, based on intellectual property ... Israel ,s foremost medical research center, ... Neurosciences Ltd., received significant funding from the Israeli ... Chief Scientist (OCS) to support product development and ...
(Date:5/23/2013)... May 23, 2013  The need to add ... continuum was highlighted prominently at the 108 th ... (AUA), in San Diego.  According to SonaCare Medical, ... ultrasound (HIFU) technology, the need for image-guided technologies ... urologists to consider minimally invasive ablative treatments, was ...
Breaking Medicine Technology:First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6
... -- MUMBAI, India, October 20, 2010 ... ... (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... = ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. for ...
... (Nasdaq: STXS ) announced today that ... and educational video sharing web portal for the ... electrophysiology (EP) and interventional cardiology (IC) procedures from ... Network utilizes Stereotaxis, state-of-the-art Odyssey technology platform to ...
Cached Medicine Technology:Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis) 2Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis) 3Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis) 4Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis) 5Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis) 6Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis) 7Cipla Launches the World's First Generic Pirfenidone in India, Giving Hope to Sufferers of IPF (Idiopathic Pulmonary Fibrosis) 8Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training 2Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training 3Stereotaxis Launches the Odyssey Interventional Network for Superior Online Cardiovascular Education and Training 4
(Date:5/24/2013)... mutations central to the development of infantile myofibromatosis (IM)a ... and soft tissuemay provide new therapeutic targets, according to ... Sinai. The findings, published in the American Journal ... options for this debilitating disease, for which the only ... tumors. , IM is an inheritied disorder that develops ...
(Date:5/24/2013)... Mike Stoler believes that there is much to be ... York. That’s why he hosts “Building New York—New ... And that’s why he invited Robert Glazer, Chief Executive ... single specialty practice in the greater New York area, ... and sub-specialists service communities throughout New York and New ...
(Date:5/24/2013)... May 24, 2013 6Webs.com has educated ... out a home security monitoring provider. The ... 6Webs.com the useful resource consumers prefer for unbiased and ... their evaluations of the leading wireless home security system ... are rated on a number of key factors including ...
(Date:5/24/2013)... Bethesda, MD (PRWEB) May 24, 2013 ... to its growing base of clients. As a result ... reports a presence in 20 states around the ... providing medical transcription services to the healthcare industry ... nurses who use their years of clinical work ...
(Date:5/24/2013)... (HealthDay News) -- The number of U.S. patients ... time in an emergency room has increased by ... The study, conducted by researchers at the George ... Services in Washington, D.C., found that patients wait ... before being admitted to the ICU. The researchers ...
Breaking Medicine News(10 mins):Health News:Researchers identify first drug targets in childhood genetic tumor disorder 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 3Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 4Health News:2013 Best Wireless Security System Providers Reported by 6Webs.com 2Health News:The Dictation Source Signs Two National Hospital Chains 2Health News:The Dictation Source Signs Two National Hospital Chains 3Health News:Sharp Rise in ICU Admissions From U.S. Emergency Rooms 2
... Reporter , WEDNESDAY, Oct. 13 (HealthDay News) -- People taking ... or treat osteoporosis may be at risk for a rare ... warned Wednesday. Bisphosphonates work by inhibiting bone loss ... Whether bisphosphonates are the cause of these rare thigh fractures ...
... to give back to the cancer communities in the ... Society for Radiation Oncology (ASTRO) is partnering with Mama,s ... survivorship issues. , Mama,s Kitchen will work with ASTRO ... 52nd Annual Meeting, scheduled for October 31-November 4, 2010, ...
... Gerontological Society of America (GSA) and the National ... PhD, and Tony Noice, PhD, of Elmhurst College as the ... in Creativity and Aging . This award recognizes and ... in the field of creativity and aging shifted the conceptual ...
... By Serena Gordon HealthDay Reporter , TUESDAY, Oct. ... five siblings of children with autism may have subtler problems ... 3,000 children. What isn,t yet clear is if these ... or exactly what type of intervention, if any, might be ...
... Douglas A. Jabs, MD, MBA, Professor and Chair of ... Associates, and Dean for Clinical Affairs at The Mount ... prestigious Jackson Memorial Lecture at the 2010 Annual Meeting ... be published in the November issue of the ...
... systems and symbols on the fronts of food packaging ... four nutrients of greatest concern calories, saturated fat, ... from the Institute of Medicine. These food components ... health problems affecting many Americans, including obesity, heart disease, ...
Cached Medicine News:Health News:Bone Drugs Linked to Rare Fractures, FDA Warns 2Health News:Bone Drugs Linked to Rare Fractures, FDA Warns 3Health News:Noices to receive 2010 Gene D. Cohen Award 2Health News:Siblings of Autistic Children May Also Have Subtle Traits 2Health News:Siblings of Autistic Children May Also Have Subtle Traits 3Health News:Douglas A. Jabs, M.D., honored with Jackson Memorial Lecture by the American Academy of Ophthalmology 2Health News:Douglas A. Jabs, M.D., honored with Jackson Memorial Lecture by the American Academy of Ophthalmology 3Health News:Nutrition rating enhancing front-of-package nutrition rating systems and symbols: Phase 1 2
... Atlas monitor is a low-cost, multi-parameter monitor ... procedures, and surgery. The large display provides ... visible from across the room. The intuitive ... operate the monitor in just minutes., ...
... needed for quality, comprehensive portable and bedside ... allows you to see up to four ... touch screen allows easy navigation through menus ... temperature., ,Standard features include two channels ...
... anesthesia monitor., ,The Cardiocap/5 is ... use in the operating room, ambulatory ... The Cardiocap/5 offers full vital signs ... oxygenation and circulation to advanced airway ...
... for Clinical Professionals and Researchers., ,S/5 Collect ... and efficient way to collect data from Datex-Ohmeda ... days at selectable time intervals. With S/5 Collect ... the monitor via an interface cable or connect ...
Medicine Products: